"Gene Editing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Genetic engineering techniques that involve DNA REPAIR mechanisms for incorporating site-specific modifications into a cell's genome.
| Descriptor ID |
D000072669
|
| MeSH Number(s) |
E05.393.420.270
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gene Editing".
Below are MeSH descriptors whose meaning is more specific than "Gene Editing".
This graph shows the total number of publications written about "Gene Editing" by people in this website by year, and whether "Gene Editing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2016 | 4 | 1 | 5 |
| 2017 | 7 | 1 | 8 |
| 2018 | 11 | 6 | 17 |
| 2019 | 5 | 7 | 12 |
| 2020 | 5 | 6 | 11 |
| 2021 | 5 | 11 | 16 |
| 2022 | 8 | 3 | 11 |
| 2023 | 6 | 1 | 7 |
| 2024 | 5 | 4 | 9 |
| 2025 | 7 | 5 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Editing" by people in Profiles.
-
Next-generation multiplex-edited CAR-NK cells: more edits, more power? J Immunother Cancer. 2025 Sep 15; 13(9).
-
AsCas12a tolerates insertions in target DNA. Nucleic Acids Res. 2025 Sep 05; 53(17).
-
Hide-and-Seek genome editing reveals that Gephyrin is required for axo-axonic synapse assembly. Proc Natl Acad Sci U S A. 2025 Aug 12; 122(32):e2500726122.
-
Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases. Prog Retin Eye Res. 2025 Jul; 107:101376.
-
CRISPR-Cas9 engineering of human T regulatory cells - Design and optimization of a manufacturing process. Mol Immunol. 2025 Aug; 184:13-21.
-
Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing. Mol Cell. 2025 May 01; 85(9):1730-1742.e9.
-
CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 2025 Jul; 108(1):145-149.
-
Gene therapy for inborn errors of immunity: Current clinical progress. Ann Allergy Asthma Immunol. 2025 Jun; 134(6):630-638.
-
The Central Role of Cytochrome P450 Reductase (CPR) in Hyperoxic Lung Injury. Expert Opin Drug Metab Toxicol. 2025 May; 21(5):589-598.
-
In vivo expansion of gene-targeted hepatocytes through transient inhibition of an essential gene. Sci Transl Med. 2025 Feb 12; 17(785):eadk3920.